Increased interleukin-6 levels associate with worse 1-year outcome after acute myocardial infarction and link infarct size, impaired iron status and heart failure
Interleukin 6 (IL-6) has attracted attention as a key contributor to deleterious pro-inflammatory processes in patients after acute myocardial infarction (AMI). IL-6 may also worsen heart failure (HF) by disrupting iron metabolism. However, data about IL-6 in these settings remain incomplete. To assess the...